In an internal email sent by Chen Fangyi, founder of the female-focused health app Meet You, it was stated that Meet You had completed a new round of financing and would announce it soon. In fact, the transaction was completed half a month ago, with a financing amount of 1 billion RMB. The investors could not disclose too much information, but it is said that almost all existing shareholders participated in this round.
Judging from Meet You’s financing history, this marks the company’s fifth round of funding. In the female health market, “Da Yi Ma,” which also entered the sector through menstrual cycle management, announced in October last year that it had secured RMB 130 million in Series E financing, led by Haitong Kaiyuan Investment Co., Ltd., with additional investments from By-Health and its founder Chai Ke. It remains unclear which company will be the first to achieve a successful exit.
Recent data released by Meet You indicates that the company has achieved profitability at scale, with net profit exceeding RMB 10 million in the second quarter of this year. The company has recorded three consecutive months of net profit growth, with a monthly growth rate surpassing 50%. Meanwhile, its Daily Active Users (DAU) are more than three times those of its closest competitor. Beyond its two primary revenue streams—advertising and e-commerce—“You Baobao,” the pregnancy management tool under Meet You, has initiated independent financing rounds, reportedly receiving an independent valuation of USD 200 million from investors.
The development logic of Meet You is quite easy to understand, after all, pure menstrual cycle management makes for a rather thin narrative. Targeting vertical user segments and covering longer stages of users’ lives is the direction they are currently exploring, thereby expanding their growth potential.
Appendix: Meet You’s Financing History:
April 2013, Series A, millions of RMB, Xianfeng Changqing
January 2014, Series B, $15 million, led by Matrix Partners China, with participation from Xianfeng Changqing
June 2014, Series C, $35 million, led by SIG, with follow-on investments from Matrix Partners China and Xianfeng Changqing
December 2015, Series D, tens of millions of U.S. dollars, led by Cathay Capital, with Matrix Partners China participating
Reprinted from: 36Kr